CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
October 2021—Thermo Fisher Scientific announced a suite of Ion Torrent Oncomine immune repertoire assays designed to detect potentially malignant clones of T cells and B cells. Using proprietary Ion AmpliSeq technology, the pan-clonality assays target multiple parts of the B- and T-cell immune receptors using a single reaction with ultra-high sensitivity.
The assays are available on the Ion GeneStudio S5 system and feature integrated analysis and data visualization tools that aim to simplify the interpretation of results for laboratories and health care professionals. The assays are for research use only.
Pages: 1 2